US Stock MarketDetailed Quotes

PTPI Petros Pharmaceuticals

Watchlist
  • 0.5860
  • +0.0379+6.91%
Close May 17 16:00 ET
  • 0.5990
  • +0.0130+2.22%
Post 16:09 ET
4.10MMarket Cap-79P/E (TTM)

Petros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Petros Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

-364.25K

-145.64%
EPS(YoY)

-2.17

-6.90%
Analyst Rating

Buy

Feb 29, 2024

Petros Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.404M--
--2024/Q2-- / 1.429M--
--2024/Q11.389M / 1.454M--
--2023/Q4-- / 1.553M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.404M--
--2024/Q2-- / 1.429M--
--2024/Q11.389M / 1.454M--
--2023/Q4-- / 1.553M--

Petros Pharmaceuticals Earnings Reports

  • Petros Pharmaceuticals | 10-Q: Quarterly report

    May 15 16:06

  • Petros Pharmaceuticals | 10-K: Annual report

    Apr 1 15:35

  • Petros Pharmaceuticals: Q3 2023 Earnings Report

    Nov 15, 2023 16:11

  • Petros Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:03

    • Read more

    Analysis

    Analyst Rating

    Updated: Feb 29, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg